Skip to main content
. Author manuscript; available in PMC: 2021 Aug 20.
Published in final edited form as: Cancer Gene Ther. 2020 Jul 20;28(7-8):799–812. doi: 10.1038/s41417-020-0196-5

Figure 2.

Figure 2.

Evaluation of the NET-specific targeting of our anti-SSTR2 antibody using IHC of normal human organs. A, Surface SSTR2 staining in 33 normal human organs (US Biomax, FDA662a, n = 2), including cerebrum, cerebellum, peripheral nerve, adrenal gland, thyroid gland, spleen, thymus, bone marrow, lymph node, tonsil, pancreas, liver, esophagus, stomach, small intestine, colon, lung, salivary, pharynx, kidney, bladder, testis, prostate, penis, ovary, uterine tube, breast, endometrium, cervix, cardiac muscle, skeletal muscle, mesothelium, and skin. B, Representative high-resolution IHC imaging of cerebellum, cerebrum, liver, lung, skin, tonsil, prostate, and pancreas. Scale bar equals 50 μm.